The Indian pharmaceutical industry plays a key role in supplying drugs to the United States, complicating efforts to relocate generic production. Nearly 90% of prescriptions in the United States are generics, with 40% coming from India. Although tariffs are being proposed, experts warn that this could lead to increased costs and shortages of essential medications.